NASDAQ:CLVR Clever Leaves Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.03 +0.06 (+6.19%) (As of 07/5/2022 04:00 PM ET) Add Compare Share Today's Range$0.94▼$1.0450-Day Range$0.96▼$1.4652-Week Range$0.91▼$12.40Volume151,109 shsAverage Volume314,813 shsMarket Capitalization$31.02 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Clever Leaves MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside385.4% Upside$5.00 Price TargetShort InterestHealthy3.52% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.97Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.68 out of 5 starsMedical Sector880th out of 1,428 stocksPharmaceutical Preparations Industry441st out of 680 stocks 3.3 Analyst's Opinion Consensus RatingClever Leaves has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, Clever Leaves has a forecasted upside of 385.4% from its current price of $1.03.Amount of Analyst CoverageClever Leaves has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.52% of the outstanding shares of Clever Leaves have been sold short.Short Interest Ratio / Days to CoverClever Leaves has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Clever Leaves has recently decreased by 29.33%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldClever Leaves does not currently pay a dividend.Dividend GrowthClever Leaves does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLVR. Previous Next 2.8 News and Social Media Coverage News SentimentClever Leaves has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Clever Leaves this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for CLVR on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Clever Leaves to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clever Leaves insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.80% of the stock of Clever Leaves is held by insiders.Percentage Held by InstitutionsOnly 31.69% of the stock of Clever Leaves is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Clever Leaves is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clever Leaves is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClever Leaves has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CLVR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter. Email Address About Clever Leaves (NASDAQ:CLVR) StockClever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.Read More CLVR Stock News HeadlinesJuly 3, 2022 | americanbankingnews.comClever Leaves (NASDAQ:CLVR) Trading Down 0.6%June 8, 2022 | msn.comCantourage And Clever Leaves Intensify Partnership For Distribution Of Medical Cannabis In GermanyMay 17, 2022 | finance.yahoo.comEven after rising 11% this past week, Clever Leaves Holdings (NASDAQ:CLVR) shareholders are still down 87% over the past three yearsMay 13, 2022 | seekingalpha.comClever Leaves Holdings Inc. (CLVR) CEO Andrés Fajardo on Q1 2022 Results - Earnings Call TranscriptMay 13, 2022 | finance.yahoo.comClever Leaves Reports First Quarter 2022 ResultsMay 12, 2022 | benzinga.comClever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2MMay 12, 2022 | seekingalpha.comClever Leaves Q1 2022 Earnings PreviewMay 11, 2022 | finance.yahoo.comClever Leaves to Participate in Upcoming May Investor ConferencesApril 28, 2022 | finance.yahoo.comClever Leaves to Hold First Quarter 2022 Conference Call on May 12, 2022 at 5:00 p.m. ETApril 27, 2022 | seekingalpha.comClever Leaves German affiliate becomes fully licensed medical cannabis distributor in GermanyApril 27, 2022 | finance.yahoo.comClever Leaves Germany GmbH Becomes a Fully Licensed Medical Cannabis Distributor in GermanyApril 20, 2022 | seekingalpha.comClever rises 5% and enhances presence in the US with Biom Therapeutics partnershipApril 20, 2022 | msn.comClever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical TrialsApril 20, 2022 | finance.yahoo.comClever Leaves Strengthens Its Presence in the U.S. Through Partnership With Biom TherapeuticsApril 5, 2022 | finance.yahoo.comClever Leaves to Present at Upcoming April Investor ConferencesApril 4, 2022 | seekingalpha.comClever Leaves plans to export dried flower from Colombia in 2022April 4, 2022 | finance.yahoo.comClever Leaves Ready to Export Dried Flower From ColombiaMarch 28, 2022 | seekingalpha.comClever Leaves crashes after sharp rally last weekMarch 28, 2022 | seekingalpha.comClever Leaves stock slumps as Cowen slashes price targetMarch 25, 2022 | msn.comWhy Clever Leaves Stock Is Trading Higher And What Investors Need To KnowMarch 25, 2022 | investorplace.comWhy Is Clever Leaves (CLVR) Stock Up Today?March 24, 2022 | seekingalpha.comClever Leaves stock soars postmarket on strong earningsMarch 24, 2022 | benzinga.comClever Leaves Reports Fourth Quarter And Full Year 2021 ResultsMarch 23, 2022 | benzinga.comA Preview Of Clever Leaves Holdings's EarningsMarch 17, 2022 | finance.yahoo.comClever Leaves Appoints William Muecke to Board of DirectorsSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLVR CUSIPN/A CIK1819615 Webwww.cleverleaves.com Phone646-880-4382FaxN/AEmployees560Year FoundedN/ACompany Calendar Last Earnings5/12/2022Today7/05/2022Next Earnings (Estimated)8/11/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$5.00 High Stock Price Forecast$7.00 Low Stock Price Forecast$4.00 Forecasted Upside/Downside+385.4%Consensus RatingModerate Buy Rating Score (0-4)2.66666666666667 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,730,000.00 Net Margins-280.95% Pretax Margin-274.53% Return on Equity-50.18% Return on Assets-30.22% Debt Debt-to-Equity Ratio0.07 Current Ratio2.52 Quick Ratio1.93 Sales & Book Value Annual Sales$15.37 million Price / Sales2.02 Cash FlowN/A Price / Cash FlowN/A Book Value$2.74 per share Price / Book0.38Miscellaneous Outstanding Shares30,120,000Free Float27,471,000Market Cap$31.02 million OptionableOptionable Beta1.16 Clever Leaves Frequently Asked Questions Should I buy or sell Clever Leaves stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clever Leaves in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Clever Leaves stock. View analyst ratings for Clever Leaves or view top-rated stocks. What is Clever Leaves' stock price forecast for 2022? 3 brokers have issued 1 year target prices for Clever Leaves' shares. Their CLVR stock forecasts range from $4.00 to $7.00. On average, they predict Clever Leaves' stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 385.4% from the stock's current price. View analysts' price targets for Clever Leaves or view top-rated stocks among Wall Street analysts. How has Clever Leaves' stock price performed in 2022? Clever Leaves' stock was trading at $3.10 on January 1st, 2022. Since then, CLVR stock has decreased by 66.8% and is now trading at $1.03. View the best growth stocks for 2022 here. When is Clever Leaves' next earnings date? Clever Leaves is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Clever Leaves. How were Clever Leaves' earnings last quarter? Clever Leaves Holdings Inc. (NASDAQ:CLVR) released its earnings results on Thursday, May, 12th. The company reported ($0.52) earnings per share for the quarter. The business had revenue of $5.22 million for the quarter. Clever Leaves had a negative net margin of 280.95% and a negative trailing twelve-month return on equity of 50.18%. View Clever Leaves' earnings history. What guidance has Clever Leaves issued on next quarter's earnings? Clever Leaves issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $20.00 million-$25.00 million, compared to the consensus revenue estimate of $22.75 million. Who are Clever Leaves' key executives? Clever Leaves' management team includes the following people: Mr. Andres Fajardo, Co-Founder, CEO & Director (Age 44, Pay $231.55k)Mr. Henry R. Hague III, Chief Financial Officer (Age 50, Pay $267.86k)Mr. David M. Kastin Esq., Gen. Counsel & Corp. Sec. (Age 54)Diana Sigüenza, Strategic Communications DirectorMr. Amit Pandey, Exec. VP of Fin. (Age 40)Mr. Julian Wilches, Chief Regulatory Officer (Age 43)Mr. Andrew Miller, Head of Commercial EMEA, North America, & Asia- PacificMr. Gustavo Escobar, Global Head of Flower BUMr. Camilo Bohorquez, Head of ColombiaMs. Caroline Kliess, Managing Director of Germany Who are some of Clever Leaves' key competitors? Some companies that are related to Clever Leaves include Applied Molecular Transport (AMTI), Nanobiotix (NBTX), MediciNova (MNOV), Gelesis (GLS), Anebulo Pharmaceuticals (ANEB), LumiraDx (LMDX), Puma Biotechnology (PBYI), Akouos (AKUS), ESSA Pharma (EPIX), Enochian Biosciences (ENOB), RVL Pharmaceuticals (RVLP), Otonomy (OTIC), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM) and Actinium Pharmaceuticals (ATNM). View all of CLVR's competitors. What is Clever Leaves' stock symbol? Clever Leaves trades on the NASDAQ under the ticker symbol "CLVR." How do I buy shares of Clever Leaves? Shares of CLVR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Clever Leaves' stock price today? One share of CLVR stock can currently be purchased for approximately $1.03. How much money does Clever Leaves make? Clever Leaves (NASDAQ:CLVR) has a market capitalization of $31.02 million and generates $15.37 million in revenue each year. The company earns $-45,730,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis. How many employees does Clever Leaves have? Clever Leaves employs 560 workers across the globe. How can I contact Clever Leaves? Clever Leaves' mailing address is 800 WESTCHESTER AVENUE SUITE 632, RYE BROOK NY, 10573. The official website for Clever Leaves is www.cleverleaves.com. The company can be reached via phone at 646-880-4382 or via email at wskolnick@samco.net. This page (NASDAQ:CLVR) was last updated on 7/5/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
